Docus

The first AI layer powering next-gen diagnostic labs with actionable insights and smarter workflows.

10/28/2026

🧬 We’re pleased to announce our new partnership with Prime Diagnostics Laboratory, a US-based high-complexity clinical laboratory with facilities in Georgia and Florida, specializing in molecular RT-PCR testing and comprehensive diagnostic services.

From infectious disease detection to routine blood testing, Prime Diagnostics supports healthcare providers with timely, accurate results.

Through this collaboration, we're bringing Docus AI into an environment where precision, speed, and meaningful clinical insights matter.

🤝 Looking forward to growing together!

10/23/2026

🧪 Toxicology results tell a more complete story when interpreted in context.

4 pages of drug testing results → 1 page of clinical interpretation.

Docus connects results with medications and testing history to highlight:

• Expected and unexpected findings
• Potential drug–drug interaction concerns
• Changes over time and what needs follow-up

The interpretation explains how the findings fit together and why they matter - helping physicians focus their review.

More useful reports for physicians. More value from your lab.

Message us for a sample.

10/02/2026

🔬 We’re excited to welcome Centennial State Lab to the Docus AI network! 🇺🇸

Serving the Rocky Mountain region, Centennial State Lab specializes in infectious disease PCR testing, with a strong commitment to fast, reliable results and supporting physicians.

Through this partnership, Docus adds clinical interpretation and medication guidance to their PCR reports. These reports help physicians understand complex findings in the patient’s context and identify relevant next steps.

We’re proud to work with their team and support the providers who rely on their results.

09/15/2026

🔬 Vero DX is now part of the growing network of laboratories powered by Docus AI.

With locations across North Carolina, Michigan, and Illinois, Vero DX is now using Docus AI to enhance its infectious disease PCR testing with AI-powered clinical reports and medication guidance for physicians.

For each infectious disease case, Docus AI helps transform complex PCR results into concise, physician-facing reports that support clinical interpretation and provide relevant medication guidance based on the laboratory findings and patient context.

The goal is simple: help laboratories go beyond delivering test results and provide physicians with more actionable clinical information at the point of care.
We’re excited to have Vero DX in the Docus AI network and to support their teams.

More to come ✨

08/26/2026

🧪 Docus AI is partnering with London Health Company, CQC-regulated UK laboratory offering private blood testing with convenient at-home sample collection.

Together, we’re exploring how AI can add more value across the diagnostic journey and support the next generation of digital-first lab experiences.

Excited to have London Health Company join the Docus AI network ✨

08/18/2026

🤝 We're excited to announce that Docus AI has signed a partnership agreement with CrelioHealth, our newest LIS partner.

Labs using CrelioHealth can now enhance their lab results with Docus AI, generating AI-powered clinical reports for physicians and patient-friendly explanations, directly within the LIS they already use.

What this means for CrelioHealth labs:

🔹 Clinical reports with differential diagnoses and follow-up plans for ordering physicians
🔹 Clear, patient-friendly result explanations that reduce call-backs and boost engagement
🔹 No workflow changes, everything runs through the existing CrelioHealth integration

This partnership is another step toward helping laboratories adopt AI without changing the systems they already trust.

More to come ✨

08/05/2026

ADLM 2026 - thank you, Anaheim!👋

Last week, hundreds of laboratory professionals stopped by booth #2354 to see how AI can transform the way labs deliver results, stay compliant, and streamline requisitions.

To every lab director, pathologist, and partner who visited, asked hard questions, and shared your challenges: thank you. Your input directly shapes our roadmap.

We're excited about what Docus AI will become - together with you.

Missed us at the show? Let's talk: docus.ai

07/27/2026

🇭🇺 Docus AI is now live in Hungary.

ProLabor is the first lab launched through our new partnership with Medion - a trusted provider of lab solutions to Hungarian laboratories.

What Prolabor's patients get with every result:

✅ AI interpretation reports in plain language
✅ Interactive biomarker charts to track trends over time
✅ An AI assistant to answer their questions
✅ Smart reminders for follow-up testing

For the lab, it means happier patients, fewer support calls, and a service competitors can't match.

First lab live. More on the way with Medion.

07/17/2026

Most labs stop at delivering results.
But follow-up care is where long-term patient engagement begins.

🔔🔄️With Docus AI Follow-Up Recommendations, labs can automatically detect when follow-up is needed and match it to the right test based on lab results and patient history.

▫️ AI-powered follow-up detection and matching
▫️ Automated reminder scheduling
▫️ Patient notifications through existing lab channels
▫️ Consultation and follow-up planning for continuity of care

Designed to help labs bring patients back at the right time and increase retention beyond the initial test.

Learn more: https://docus.ai/lab-follow-up-tests

07/09/2026

🌎🇦🇲We’re excited to partner with Astghik Medical Center, a multidisciplinary medical center with advanced laboratory services.

This partnership brings Docus AI closer to everyday diagnostic workflows, supporting more connected and intelligent lab experiences.

Another step in building the future of AI-powered diagnostics together.

Address

2810 N Church Street
Wilmington, DE
19802

Website

https://docus.ai/

Alerts

Be the first to know and let us send you an email when Docus posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.